secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEXGEL, INC. (NXGL)
CIK:        0001468929
Form:       8-K
Filed at:   2025-01-22T23:59:59+00:00
Accession:  0001493152-25-003153
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NEXGEL prelim Q4 rev ~$3M, FY2024 ~$8.6M (+100% YoY); guides FY2025 >$13M, cash flow positive
--------------------------------------------------------------------------------

- Preliminary Q4 2024 revenue ~$3.0M; full year ~$8.6M, representing >100% YoY growth for third consecutive year.
- 2025 guidance: at least $13M revenue and positive cash flow from operations during the year.
- Silly George run rate grew from $2M to >$5M post-acquisition (May 2024); new beauty under-eye patch planned.
- Contract manufacturing added two large international customers; one began Q4 revenue, other expected Q1 2025.
- Medagel to launch SilverSeal wound kit and burn pads; Kenkoderm to expand into new indication Q3 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468929/000149315225003153/0001493152-25-003153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468929/000149315225003153/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-003153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer